An Unprecedented Triad: Simultaneous Acute Pancreatitis, Axonal Polyneuropathy, and Type 1 Diabetes Mellitus in a Catastrophic Juvenile Lupus Flare [PDF]
A 14‐year‐old female with juvenile systemic lupus erythematosus (jSLE) presented with a life‐threatening and previously unreported triad: the simultaneous onset of acute pancreatitis, severe axonal polyneuropathy, and autoimmune Type 1 Diabetes (T1D ...
Laiba Hashmi +11 more
doaj +3 more sources
Objective. Identifying new markers of juvenile systemic lupus erythematosus (JSLE) is critical event to predict patient stratification and prognosis. The aim of the present study is to analyze alteration of urinary protein expression and screen potential
Song Zhang +15 more
doaj +2 more sources
A novel potential target of IL‐35‐regulated JAK/STAT signaling pathway in lupus nephritis
Background In this study, we have investigated the potential regulatory mechanisms of IL‐35 to relieve lupus nephritis (LN) through regulating Janus kinase (JAK)/signal transducers and activators of transcription (STAT) signaling pathway in mesangial ...
Zhe Cai +9 more
doaj +2 more sources
Do classic blood biomarkers of JSLE identify active lupus nephritis? Evidence from the UK JSLE Cohort Study [PDF]
Background Lupus nephritis (LN) affects up to 80% of juvenile-onset systemic lupus erythematosus (JSLE) patients. The value of commonly available biomarkers, such as anti-dsDNA antibodies, complement (C3/C4), ESR and full blood count parameters in the identification of active LN remains uncertain.
Smith, EMD, Jorgensen, AL, Beresford, MW
openaire +3 more sources
Neutrophil function in juvenile systemic Lupus Erythematosus (JSLE) [PDF]
Objectives This project aimed to investigate the abnormal neutrophil functions in terms of cell survival, phagocytosis, ROS production and chemotaxis in JSLE patients. Furthermore, factors that could affect normal neutrophil functions (such as patient sera, recombinant human cytokines and commonly-used medications) were investigated.
Chiewchengchol, Direkrit
openaire +3 more sources
COVID19‐Related Onset and Relapses of Juvenile Systemic Lupus Erythematosus‐Like Disease [PDF]
Journal of Paediatrics and Child Health, Volume 61, Issue 8, Page 1318-1321, August 2025.
Chiara Cannata +3 more
wiley +2 more sources
JSLE and the NLRP3 inflammasome – a novel therapeutic target [PDF]
Introduction: Juvenile-onset Systemic Lupus Erythematosus (JSLE) is a severe autoimmune disease causing organ damage and long-term morbidity. Impaired clearance of nuclear debris from cells and upregulated circulating damage-associated molecular patterns (DAMPs) and cytokines are thought to trigger cell death and thus, further increase release of pro ...
Gamble, J
core +6 more sources
Interdisciplinary Clinical Practice Guidelines for patient-centred management of juvenile-onset systemic lupus erythematosus [PDF]
: Objectives: To develop updated interdisciplinary clinical practice guidelines for the management of juvenile-onset systemic lupus erythematosus (jSLE) in a patient-centred, treat-to-target (T2T) approach.
Kirsten Mönkemöller +29 more
doaj +2 more sources
Investigating phagocytic markers in Juvenile-onset Systemic Lupus Erythematosus (JSLE) monocytes and macrophages [PDF]
Background Juvenile-onset systemic lupus erythematosus (JSLE) is a chronic, severe, multi-systemic autoimmune disease. Impaired phagocytic function has been implicated as an initial step in the pathogenesis of this disease, in relation to the clearance of cells undergoing apoptosis. The apoptotic process has been shown to be dysregulated in neutrophils,
Harris, David
openaire +3 more sources
TNFSF4/OX40L and IKZF1/IKAROS Genetic Variant Associations with Egyptian Juvenile Systemic Lupus Erythematosus (JSLE) [PDF]
Background: The etiopathogenesis of juvenile systemic lupus erythematosus (JSLE), a complex and complicated illness, is unknown. Genetic, environmental, and dysregulated immune system responses are all thought to contribute to the disease’s etiology ...
Zeinab R. Attia +8 more
doaj +2 more sources

